About Biopharmaceutical Research
Biopharmaceutical Research is a private company based in Castroville, California. It has reported $28,499,364 raised in five offerings on Form D since October 2020. Its chief executive is George Hodgin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2023 | Aug 9, 2023 | $676,065fully sold | 1 | $676K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 5, 2022 | Jul 14, 2022amended Jun 20, 2023 | $23,156,923fully sold | 36 | $643K | Equity, Total Offering Amount includes the amount related to the conversion of notes into shares of Series A Preferred Stock. The issuance of such convertible notes was reported in September 2020 as a debt and option right to acquire another security.Rule 506(b) | Form D/A ↗1 earlier filing |
| Feb 8, 2022 | Feb 17, 2022amended Mar 18, 2022 | $2,535,500of $5.0M target | 22 | $115K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 10, 2021 | Dec 20, 2021 | $85,876fully sold | 1 | $85,876 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 18, 2020 | Oct 2, 2020 | $2,045,000of $3.0M target | 17 | $120K | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $28,499,364 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Biopharmaceutical Research's Form D filed Aug 9, 2023.
CS
Charles Schumacher
Director
On every Form D that Biopharmaceutical Research has filed: 7 filings, from Oct 2, 2020 to Aug 9, 2023.
DW
David Weinmann
Executive officer
First appears on the Form D that Biopharmaceutical Research filed on August 9, 2023; on 1 of its 7 filings.
GH
George Hodgin
Chief Executive Officer and director
On every Form D that Biopharmaceutical Research has filed: 7 filings, from Oct 2, 2020 to Aug 9, 2023.
OI
Osagie Imasogie
Director
First appears on the Form D that Biopharmaceutical Research filed on August 9, 2023; on 1 of its 7 filings.
Earlier filings also listed
- Edward Goodwin · directorLast listed on the amended Form D that Biopharmaceutical Research filed on June 20, 2023; on 2 of its 7 filings.